Additional file 1 of Two rare flavonoid glycosides from Litsea glutinosa (Lour.) C. B. Rob.: experimental and computational approaches endorse antidiabetic potentiality
Creators: name: Bulbul, Israt Jahan
name: Hossain, Md. Jamal
name: Haque, Mohammad Rashedul
name: Al-Mansur, Muhammad Abdullah
name: Hasan, Choudhury M.
name: Al Hasan, Abdullah
name: Rashid, Mohammad A.
Publisher: name: figshare
Year: 2024
Subjects: Biochemistry
Medicine
Molecular Biology
Pharmacology
Environmental Sciences not elsewhere classified
Chemical Sciences not elsewhere classified
Biological Sciences not elsewhere classified
Cancer

description: Additional file 1: Figure S1. ESI-MS spectrum of 4΄-O-methyl (2″,4″-di-E-p-coumaroyl) afzelin (compound 1). Figure S2. ESI-MS spectrum of 4΄-O-methyl (2″,4″-di-E-p-coumaroyl) afzelin (compound 1). Figure S3. 1H-NMR spectrum (400 MHz, CD3OD) of 4΄-O-methyl (2″,4″-di-E-p-coumaroyl) afzelin (compound 1). Figure S4. 1H-NMR spectrum (400 MHz, CD3OD) of 4΄-O-methyl (2″,4″-di-E-p-coumaroyl) afzelin (compound 1) (expanded). Figure S5. 1H-NMR spectrum (400 MHz, CD3OD) of 4΄-O-methyl (2″,4″-di-E-p-coumaroyl) afzelin (compound 1) (expanded). Figure S6. 1H-NMR spectrum (400 MHz, CD3OD) of 4΄-O-methyl (2″,4″-di-E-p-coumaroyl) afzelin (compound 1) (expanded). Figure S7. 1H-NMR spectrum (400 MHz, CD3OD) of 4΄-O-methyl (2″,4″-di-E-p-coumaroyl) afzelin (compound 1) (expanded). Figure S8. 13C-NMR spectrum (100 MHz, CD3OD) of 4΄-O-methyl (2″,4″-di-E-p-coumaroyl) afzelin (compound 1). Figure S9. 13C-NMR spectrum (100 MHz, CD3OD) of 4΄-O-methyl (2″,4″-di-E-p-coumaroyl) afzelin (compound 1) (expanded). Figure S10. 13C-NMR spectrum (100 MHz, CD3OD) of 4΄-O-methyl (2″,4″-di-E-p-coumaroyl) afzelin (compound 1) (expanded). Figure S11. 13C-NMR spectrum (100 MHz, CD3OD) of 4΄-O-methyl (2″,4″-di-E-p-coumaroyl) afzelin (compound 1) (expanded). Figure S12. HSQC spectrum (400 MHz, CD3OD) of 4΄-O-methyl (2″,4″-di-E-p-coumaroyl) afzelin (compound 1). Figure S13. HSQC spectrum (400 MHz, CD3OD) of 4΄-O-methyl (2″,4″-di-E-p-coumaroyl) afzelin (compound 1) (expanded). Figure S14. HSQC spectrum (400 MHz, CD3OD) of 4΄-O-methyl (2″,4″-di-E-p-coumaroyl) afzelin (compound 1) (expanded). Figure S15. HMBC spectrum (400 MHz, CD3OD) of 4΄-O-methyl (2″,4″-di-E-p-coumaroyl) afzelin (compound 1). Figure S16. HMBC spectrum (400 MHz, CD3OD) of 4΄-O-methyl (2″,4″-di-E-p-coumaroyl) afzelin (compound 1) (expanded). Figure S17. COSY spectrum (400 MHz, CDCl3) of 4΄-O-methyl (2″,4″-di-E-p-coumaroyl) afzelin (compound 1). Figure S18. COSY spectrum (400 MHz, CDCl3) of 4΄-O-methyl (2″,4″-di-E-p-coumaroyl) afzelin (compound 1) (expanded). Figure S19. COSY spectrum (400 MHz, CDCl3) of 4΄-O-methyl (2″,4″-di-E-p-coumaroyl) afzelin (compound 1) (expanded). Figure S20. ESI-MS spectrum of 4΄-O-methyl (2″,4″-di-E-p-coumaroyl) afzelin (compound 2). Figure S21. ESI-MS spectrum of 4΄-O-methyl (2″,4″-di-E-p-coumaroyl) afzelin (compound 2). Figure S22. 1H-NMR spectrum (400 MHz, CD3OD) of quercetin 3-O-(2″,4″-di-E-p-coumaroyl)-α-L-rhamnopyranoside (compound 2). Figure S23. 1H-NMR spectrum (400 MHz, CD3OD) of quercetin 3-O-(2″,4″-di-E-p-coumaroyl)-α-L-rhamnopyranoside (compound 2) (expanded). Figure S24. 1H-NMR spectrum (400 MHz, CD3OD) of quercetin 3-O-(2″,4″-di-E-p-coumaroyl)-α-L-rhamnopyranoside (compound 2) (expanded). Figure S25. DEPT-135 spectrum (100 MHz, CD3OD) of 4΄-O-methyl (2″,4″-di-E-p-coumaroyl) afzelin (compound 2). Figure S26. DEPT-135 spectrum (100 MHz, CD3OD) of 4΄-O-methyl (2″,4″-di-E-p-coumaroyl) afzelin (compound 2). Figure S27. HSQC spectrum (400 MHz, CD3OD) of 4΄-O-methyl (2″,4″-di-E-p-coumaroyl) afzelin (compound 2). Figure S28. HMBC spectrum (400 MHz, CD3OD) of 4΄-O-methyl (2″,4″-di-E-p-coumaroyl) afzelin (compound 2). Figure S29. COSY spectrum (400 MHz, CD3OD) of 4΄-O-methyl (2″,4″-di-E-p-coumaroyl) afzelin (compound 2). Figure S30. COSY spectrum (400 MHz, CD3OD) of 4΄-O-methyl (2″,4″-di-E-p-coumaroyl) afzelin (compound 2) (expanded). Figure S31. COSY spectrum (400 MHz, CD3OD) of 4΄-O-methyl (2″,4″-di-E-p-coumaroyl) afzelin (compound 2) (expanded). Figure S32. The collected Swiss Albino Mice for conducting pharmacological studies of L. glutinosa.